- Home
- ALGS vs OKYO Comparison
ALGS vs OKYO Comparison
Compare ALGS & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALGS
- OKYO
- Stock Information
- Founded
- ALGS 2018
- OKYO 2007
- Country
- ALGS United States
- OKYO United Kingdom
- Employees
- ALGS N/A
- OKYO N/A
- Industry
- ALGS Biotechnology: Pharmaceutical Preparations
- OKYO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ALGS Health Care
- OKYO Health Care
- Exchange
- ALGS Nasdaq
- OKYO Nasdaq
- Market Cap
- ALGS 36.0M
- OKYO 37.0M
- IPO Year
- ALGS 2020
- OKYO 2022
- Fundamental
- Price
- ALGS $5.29
- OKYO $1.85
- Analyst Decision
- ALGS Strong Buy
- OKYO Strong Buy
- Analyst Count
- ALGS 1
- OKYO 1
- Target Price
- ALGS $70.00
- OKYO $7.00
- AVG Volume (30 Days)
- ALGS 163.7K
- OKYO 198.3K
- Earning Date
- ALGS 05-06-2025
- OKYO 06-06-2025
- Dividend Yield
- ALGS N/A
- OKYO N/A
- EPS Growth
- ALGS N/A
- OKYO N/A
- EPS
- ALGS N/A
- OKYO N/A
- Revenue
- ALGS $3,270,000.00
- OKYO N/A
- Revenue This Year
- ALGS N/A
- OKYO N/A
- Revenue Next Year
- ALGS N/A
- OKYO N/A
- P/E Ratio
- ALGS N/A
- OKYO N/A
- Revenue Growth
- ALGS N/A
- OKYO N/A
- 52 Week Low
- ALGS $3.76
- OKYO $0.81
- 52 Week High
- ALGS $46.80
- OKYO $1.98
- Technical
- Relative Strength Index (RSI)
- ALGS 43.20
- OKYO 62.66
- Support Level
- ALGS $5.47
- OKYO $1.70
- Resistance Level
- ALGS $6.12
- OKYO $1.98
- Average True Range (ATR)
- ALGS 0.60
- OKYO 0.18
- MACD
- ALGS 0.12
- OKYO 0.03
- Stochastic Oscillator
- ALGS 37.30
- OKYO 80.30
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.
About OKYO OKYO Pharma Limited
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.